NFIL3 and acute lymphoblastic leukemia: Our findings displayed that NFIL3 was mostly relevant to immune checkpoints in the majority of cancers, including ESCA, STES, LUAD, CESC, HNSC, LUSC, WT, GBM, STAD, ALL, etc. (Figure 5B).